Metabolomic profiling of plasma from patients with tuberculosis by use of untargeted mass spectrometry reveals novel biomarkers for diagnosis

Journal of Clinical Microbiology

Volumn 53, Issue 12, 2015, Pages 3750-3759

  Lau, Susanna K P ^a,b   Lee, Kim Chung ^b   Curreem, Shirly O T ^b   Chow, Wang Ngai ^b   To, Kelvin K W ^a,b   Hung, Ivan F N ^b   Ho, Deborah T Y ^b   Sridhar, Siddharth ^b   Li, Iris W S ^b   Ding, Vanessa S Y ^b   Koo, Eleanor W F ^c   Wong, Chi Fong ^c   Tam, Sidney ^b   Lam, Ching Wan ^b   Yuen, Kwok Yung ^a,b   Woo, Patrick C Y ^a,b  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c GRANTHAM HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 4ALPHA FORMYL 4BETA METHYL 5ALPHA CHOLESTA 8 EN 3BETA OL; BIOLOGICAL MARKER; CERAMIDE; CHOLESTEROL SULFATE; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; MASS SPECTROMETRY; METABOLOMICS; PLASMA; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TIME OF FLIGHT MASS SPECTROMETRY; TUBERCULOSIS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UPREGULATION; ADOLESCENT; AGED; BLOOD; CHEMISTRY; FEMALE; LIQUID CHROMATOGRAPHY; MALE; METABOLOME; MIDDLE AGED; PATHOLOGY; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; METABOLOME; MIDDLE AGED; PLASMA; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; YOUNG ADULT;

EID: 84947782969     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01568-15     Document Type: Article

References (55)

1. Lai CC, Liu WL, Tan CK, Huang YC, Chung KP, Lee MR, Hsueh PR. (2011). Differences in drug resistance profiles of mycobacterium tuberculosis isolates causing pulmonary and extrapulmonary tuberculosis in a medical centre in Taiwan, 2000-2010. Int J Antimicrob Agents 38: 125-129. http://dx.doi.org/10.1016/j.ijantimicag.2011.03.016
2. Jiang Y, Dou X, Zhang W, Liu H, Zhao X, Wang H, Lian L, Yu Q, Zhang J, Li G, Chen C, Wan K. (2013). Genetic diversity of antigens Rv2945c and Rv0309 in Mycobacterium tuberculosis strains may reflect ongoing immune evasion. FEMS Microbiol Lett 347: 77-82. http://dx.doi.org/10.1111/1574-6968.12222
3. Lin H, Ding H, Guo FB, Huang J. (2010). Prediction of subcellular location of mycobacterial protein using feature selection techniques. Mol Divers 14: 667-671. http://dx.doi.org/10.1007/s11030-009-9205-1
4. Getahun H, Harrington M, OBrien R, Nunn P. (2007). Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 369: 2042-2049. http://dx.doi.org/10.1016/S0140-6736(07)60284-0
5. Marais BJ, Pai M. (2007). New approaches and emerging technologies in the diagnosis of childhood tuberculosis. Paediatr Respir Rev 8: 124-133. http://dx.doi.org/10.1016/j.prrv.2007.04.002
6. Cheng VC, Yam WC, Hung IF, Woo PC, Lau SK, Tang BS, Yuen KY. (2004). Clinical evaluation of the polymerase chain reaction for the rapid diagnosis of tuberculosis. J Clin Pathol 57: 281-285. http://dx.doi.org/10.1136/jcp.2003.012658
7. Moore DF, Curry JI. (1995). Detection and identification of mycobacterium tuberculosis directly from sputum sediments by Amplicor PCR. J Clin Microbiol 33: 2686-2691
8. Lawn SD, Kerkhoff AD, Vogt M, Wood R. (2012). Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIVassociated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis 12: 201-209. http://dx.doi.org/10.1016/S1473-3099(11)70251-1
9. Mdivani N, Li H, Akhalaia M, Gegia M, Goginashvili L, Kernodle DS, Khechinashvili G, Tang YW. (2009). Monitoring therapeutic efficacy by real-time detection of mycobacterium tuberculosis mRNA in sputum. Clin Chem 55: 1694-1700. http://dx.doi.org/10.1373/clinchem.2009.124396
10. Mohamed KH, Mobasher AA, Yousef AR, Salah A, El-Naggar IZ, Ghoneim AH, Light RW. (2001). BAL neopterin: a novel marker for cellmediated immunity in patients with pulmonary tuberculosis and lung cancer. Chest 119: 776-780. http://dx.doi.org/10.1378/chest.119.3.776
11. Blakemore R, Story E, Helb D, Kop J, Banada P, Owens MR, Chakravorty S, Jones M, Alland D. (2010). Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol 48: 2495-2501. http://dx.doi.org/10.1128/JCM.00128-10
12. Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, Safi H, Blakemore R, Lan NT, Jones-López EC, Levi M, Burday M, Ayakaka I, Mugerwa RD, McMillan B, Winn-Deen E, Christel L, Dailey P, Perkins MD, Persing DH, Alland D. (2010). Rapid detection of mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 48: 229-237. http://dx.doi.org/10.1128/JCM.01463-09
13. Olivier I, Loots DT. (2011). An overview of tuberculosis treatments and diagnostics. What role could metabolomics play? J Cell Tissue Res 11: 2655-2671
14. Olivier I, Loots DT. (2012). A metabolomics approach to characterise and identify various Mycobacterium species. J Microbiol Methods 88: 419-426. http://dx.doi.org/10.1016/j.mimet.2012.01.012
15. Meissner-Roloff RJ, Koekemoer G, Warren RM, Loots DT. (2012). A metabolomics investigation of a hyper-and hypo-virulent phenotype of Beijing lineage M. tuberculosis. Metabolomics 8: 1194-1203. http://dx.doi.org/10.1007/s11306-012-0424-6
16. Schoeman JC, Loots DT. (2011). Improved disease characterisation and diagnostics using metabolomics: a review. J Cell Tissue Res 11: 2673-2683
17. Tam EW, Chen JH, Lau EC, Ngan AH, Fung KS, Lee KC, Lam CW, Yuen KY, Lau SK, Woo PC. (2014). Misidentification of Aspergillus nomius and Aspergillus tamarii as Aspergillus flavus: characterization by internal transcribed spacer,-tubulin, and calmodulin gene sequencing, metabolic fingerprinting, and matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 52: 1153-1160. http://dx.doi.org/10.1128/JCM.03258-13
18. To KK, Fung AM, Teng JL, Curreem SO, Lee KC, Yuen KY, Lam CW, Lau SK, Woo PCY. (2013). Characterization of a Tsukamurella pseudooutbreak by phenotypic tests, 16S rRNA sequencing, pulsed-field gel electrophoresis, and metabolic footprinting. J Clin Microbiol 51: 334-338. http://dx.doi.org/10.1128/JCM.02845-12
19. Woo PC, Lam CW, Tam EW, Leung CK, Wong SS, Lau SK, Yuen KY. (2012). First discovery of two polyketide synthase genes for mitorubrinic acid and mitorubrinol yellow pigment biosynthesis and implications in virulence of Penicillium marneffei. PLoS Neglect Trop Dis 6: e1871. http://dx.doi.org/10.1371/journal.pntd.0001871
20. De Carvalho LP, Fischer SM, Marrero J, Nathan C, Ehrt S, Rhee KY. (2010). Metabolomics of mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates. Chem Biol 17: 1122-1131. http://dx.doi.org/10.1016/j.chembiol.2010.08.009
21. Dang NA, Kuijper S, Walters E, Claassens M, van Soolingen D, Vivo-Truyols G, Janssen HG, Kolk AH. (2013). Validation of biomarkers for distinguishing Mycobacterium tuberculosis from non-tuberculous mycobacteria using gas chromatography-mass spectrometry and chemometrics. PLoS One 8: e76263. http://dx.doi.org/10.1371/journal.pone.0076263
22. Layre E, Sweet L, Hong S, Madigan CA, Desjardins D, Young DC, Cheng TY, Annand JW, Kim K, Shamputa IC, McConnell MJ, Debono CA, Behar SM, Minnaard AJ, Murray M, Barry CE, III, Matsunaga I, Moody DB. (2011). A comparative lipidomics platform for chemotaxonomic analysis of mycobacterium tuberculosis. Chem Biol 18: 1537-1549. http://dx.doi.org/10.1016/j.chembiol.2011.10.013
23. Madigan CA, Cheng TY, Layre E, Young DC, McConnell MJ, Debono CA, Murry JP, Wei JR, Barry CE, III, Rodriguez GM, Matsunaga I, Rubin EJ, Moody DB. (2012). Lipidomic discovery of deoxysiderophores reveals a revised mycobactin biosynthesis pathway in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 109: 1257-1262. http://dx.doi.org/10.1073/pnas.1109958109
24. Layre E, Lee HJ, Young DC, Martinot AJ, Buter J, Minnaard AJ, Annand JW, Fortune SM, Snider BB, Matsunaga I, Rubin EJ, Alber T, Moody DB. (2014). Molecular profiling of mycobacterium tuberculosis identifies tuberculosinyl nucleoside products of the virulence-associated enzyme Rv3378c. Proc Natl Acad Sci USA 111: 2978-2983. http://dx.doi.org/10.1073/pnas.1315883111
25. Lau SKP, Lam CW, Curreem SOT, Lee KC, Lau CCY, Chow WN, Ngan AHY, To KKW, Chan JFW, Hung IFN, Yam WC, Yuen KY, Woo PCY. (2015). Identification of specific metabolites in culture supernatant of mycobacterium tuberculosis using metabolomics: exploration of potential biomarkers. Emerg Microbes Infect 4: e6. http://dx.doi.org/10.1038/emi.2015.6
26. Banday KM, Pasikanti KK, Chan EC, Singla R, Rao KV, Chauhan VS, Nanda RK. (2011). Use of urine volatile organic compounds to discriminate tuberculosis patients from healthy subjects. Anal Chem 83: 5526-5534. http://dx.doi.org/10.1021/ac200265g
27. Zhou A, Ni J, Xu Z, Wang Y, Lu S, Sha W, Karakousis PC, Yao YF. (2013). Application of 1H NMR spectroscopy-based metabolomics to sera of tuberculosis patients. J Proteome Res 12: 4642-4649. http://dx.doi.org/10.1021/pr4007359
28. Frediani JK, Jones DP, Tukvadze N, Uppal K, Sanikidze E, Kipiani M, Tran VT, Hebbar G, Walker DI, Kempker RR, Kurani SS, Colas RA, Dalli J, Tangpricha V, Serhan CN, Blumberg HM, Ziegler TR. (2014). Plasma metabolomics in human pulmonary tuberculosis disease: a pilot study. PLoS One 9: e108854. http://dx.doi.org/10.1371/journal.pone.0108854
29. Mahapatra S, Hess AM, Johnson JL, Eisenach KD, DeGroote MA, Gitta P, Joloba ML, Kaplan G, Walzl G, Boom WH, Belisle JT. (2014). A metabolic biosignature of early response to anti-tuberculosis treatment. BMC Infect Dis 14: 53. http://dx.doi.org/10.1186/1471-2334-14-53
30. Basanta M, Jarvis RM, Xu Y, Blackburn G, Tal-Singer R, Woodcock A, Singh D, Goodacre R, Thomas CL, Fowler SJ. (2010). Non-invasive metabolomics analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers. Analyst 135: 315-320. http://dx.doi.org/10.1039/b916374c
31. Zhang A, Sun H, Han Y, Yan G, Wang X. (2013). Urinary metabolic biomarker and pathway study of hepatitis B virus infected patients based on UPLC-MS system. PLoS One 8: e64381. http://dx.doi.org/10.1371/journal.pone.0064381
32. Sun H, Zhang A, Yan G, Piao C, Li W, Sun C, Wu X, Li X, Chen Y, Wang X. (2013). Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews. Mol Cell Proteomics 12: 710-719. http://dx.doi.org/10.1074/mcp.M112.019141
33. Xia J, Broadhurst DI, Wilson M, Wishart DS. (2013). Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics 9: 280-299. http://dx.doi.org/10.1007/s11306-012-0482-9
34. Tserng KY, Griffin RL. (2004). Ceramide metabolite, not intact ceramide molecule, may be responsible for cellular toxicity. Biochem J 380: 715-722. http://dx.doi.org/10.1042/bj20031733
35. Grassmé H, Gulbins E, Brenner B, Ferlinz K, Sandhoff K, Harzer K, Lang F, Meyer TF. (1997). Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells. Cell 91: 605-615. http://dx.doi.org/10.1016/S0092-8674(00)80448-1
36. Esen M, Schreiner B, Jendrossek V, Lang F, Fassbender K, Grassmé H, Gulbins E. (2001). Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells. Apoptosis 6: 431-439. http://dx.doi.org/10.1023/A: 1012445925628
37. Grassmé H, Jendrossek V, Riehle A, von Kürthy G, Berger J, Schwarz H, Weller M, Kolesnick R, Gulbins E. (2003). Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 9: 322-330. http://dx.doi.org/10.1038/nm823
38. Cannon CL, Kowalski MP, Stopak KS, Pier GB. (2003). Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator. Am J Respir Cell Mol Biol 29: 188-197. http://dx.doi.org/10.1165/rcmb.4898
39. Anes E, Kühnel MP, Bos E, Moniz-Pereira J, Habermann A, Griffiths G. (2003). Selected lipids activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria. Nat Cell Biol 5: 793-802. http://dx.doi.org/10.1038/ncb1036
40. Okino N, Ichinose S, Omori A, Imayama S, Nakamura T, Ito M. (1999). Molecular cloning, sequencing, and expression of the gene encoding alkaline ceramidase from Pseudomonas aeruginosa. Cloning of a ceramidase homologue from Mycobacterium tuberculosis. J Biol Chem 274: 36616-36622
41. Morell P, Radin NS. (1970). Specificity in ceramide biosynthesis from long chain bases and various fatty acyl coenzyme As by brain microsomes. J Biol Chem 245: 342-350
42. Lam CW, Law CY. (2014). Untargeted mass spectrometry-based metabolomic profiling of pleural effusions: fatty acids as novel cancer biomarkers for malignant pleural effusions. J Proteome Res 13: 4040-4046. http://dx.doi.org/10.1021/pr5003774
43. Vilhardt F, van Deurs B. (2004). The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly. EMBO J 23: 739-748. http://dx.doi.org/10.1038/sj.emboj.7600066
44. Clemens DL, Lee BY, Horwitz MA. (2000). Mycobacterium tuberculosis and Legionella pneumophila phagosomes exhibit arrested maturation despite acquisition of Rab7. Infect Immun 68: 5154-5166. http://dx.doi.org/10.1128/IAI.68.9.5154-5166.2000
45. Huynh KK, Gershenzon E, Grinstein S. (2008). Cholesterol accumulation by macrophages impairs phagosome maturation. J Biol Chem 283: 35745-35755. http://dx.doi.org/10.1074/jbc.M806232200
46. Wuest SJ, Crucet M, Gemperle C, Loretz C, Hersberger M. (2012). Expression and regulation of 12/15-lipoxygenases in human primary macrophages. Atherosclerosis 225: 121-127. http://dx.doi.org/10.1016/j.atherosclerosis.2012.07.022
47. Smith SM, Klein MR, Malin AS, Sillah J, McAdam KP, Dockrell HM. (2002). Decreased IFN-gamma and increased IL-4 production by human CD8() T cells in response to Mycobacterium tuberculosis in tuberculosis patients. Tuberculosis (Edinb) 82: 7-13. http://dx.doi.org/10.1054/tube.2001.0317
48. Nolan A, Fajardo E, Huie ML, Condos R, Pooran A, Dawson R, Dheda K, Bateman E, Rom WN, Weiden MD. (2013). Increased production of IL-4 and IL-12p40 from bronchoalveolar lavage cells are biomarkers of mycobacterium tuberculosis in the sputum. PLoS One 8: e59461. http://dx.doi.org/10.1371/journal.pone.0059461
49. Bafica A, Scanga CA, Serhan C, Machado F, White S, Sher A, Aliberti J. (2005). Host control of mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. J Clin Invest 115: 1601-1606. http://dx.doi.org/10.1172/JCI23949
50. Gutierrez MG, Gonzalez AP, Anes E, Griffiths G. (2009). Role of lipids in killing mycobacteria by macrophages: evidence for NF-kappaB-dependent and-independent killing induced by different lipids. Cell Microbiol 11: 406-420. http://dx.doi.org/10.1111/j.1462-5822.2008.01263.x
51. Strott CA, Higashi Y. (2003). Cholesterol sulfate in human physiology: what's it all about? J Lipid Res 44: 1268-1278. http://dx.doi.org/10.1194/jlr.R300005-JLR200
52. Huang YS, Eid K, Davignon J. (1981). Cholesteryl sulfate: measurement with-sitosteryl sulfate as an internal standard. Can J Biochem 59: 602-605. http://dx.doi.org/10.1139/o81-083
53. Tamasawa N, Tamasawa A, Takebe K. (1993). Higher levels of plasma cholesterol sulfate in patients with liver cirrhosis and hypercholesterolemia. Lipids 28: 833-836. http://dx.doi.org/10.1007/BF02536238
54. van Doormaal JJ, Muskiet FA, Jansen G, Wolthers BG, Sluiter WJ, Doorenbos H. (1986). Increase of plasma and red cell cholesterol sulfate levels in induced hypothyroidism in man. Clin Chim Acta 155: 195-200. http://dx.doi.org/10.1016/0009-8981(86)90238-X
55. Hanley K, Wood L, Ng DC, He SS, Lau P, Moser A, Elias PM, Bikle DD, Williams ML, Feingold KR. (2001). Cholesterol sulfate stimulates involucrin transcription in keratinocytes by increasing Fra-1, Fra-2, and Jun D. J Lipid Res 42: 390-398